Related Experiment Video
Updated: May 5, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
1.1K
Diagnosing and treating psoriatic arthritis: an update
W H Boehncke1, A Qureshi, J F Merola
1Geneva University Hospital, Rue Gabrielle Perret-Gentil 4, 1211, Geneva 14, Switzerland.
The British Journal of Dermatology
|November 26, 2013
Summary
Psoriatic arthritis (PsA) is an inflammatory condition affecting psoriasis patients. Early dermatologist diagnosis and treatment are crucial for managing PsA, preventing joint damage, and addressing cardiovascular risks.
Area of Science:
- Rheumatology and Dermatology
- Inflammatory Arthritis Research
Background:
- Psoriatic arthritis (PsA) affects ~25% of psoriasis patients, often developing after skin lesions appear.
- Dermatologists are uniquely positioned for early PsA detection due to psoriasis preceding joint involvement.
Purpose of the Study:
- To review the pathogenesis and comorbidities of psoriatic arthritis.
- To discuss diagnostic and screening tools for PsA.
- To present current and emerging therapeutic strategies for PsA.
Main Methods:
- Comprehensive literature review focusing on PsA pathogenesis, diagnosis, and treatment.
- Analysis of screening and imaging modalities for PsA detection and assessment.
- Review of therapeutic options, including biologics and novel agents.
Main Results:
- PsA pathogenesis remains incompletely understood but involves complex inflammatory pathways.
- Early diagnosis by dermatologists is vital to prevent irreversible joint damage and functional disability.
- PsA is linked to significant cardiovascular comorbidities, necessitating integrated management.
Conclusions:
- Dermatologists play a pivotal role in the early identification and management of psoriatic arthritis.
- Accurate diagnosis guides distinct therapeutic strategies compared to psoriasis alone.
- Addressing PsA comorbidities, particularly cardiovascular risks, is essential for comprehensive patient care.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
548
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
548
01:26Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
01:11Genome-wide Association Studies-GWAS
12.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.7K
01:20The JAK-STAT Signaling Pathway
10.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10.2K
01:27Peripheral Artery Disease III: Interprofessional Care
659
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K